They tried a few tricks: DPP-4-resistant versions: tweaking the GLP-1 molecule so DPP-4 cant see where to cut it Fatty acid tails: causing the GLP-1 to latch onto albumin in your blood, hiding from DPP-4 Encapsulation: wrapping the molecule in protective coatings so it survives longer before being exposed to enzymes These hacks meant the drug could hang out in the bloodstream for hours, or even days, instead of minutes
Dosing protocols from starting dose through maintenance
The needle is typically only 4mm to 5mm long, which is too short to reach the muscle in recommended injection areas like the abdomen or thigh
While the results of the trial are dramatic, the fact is that before all the noise around GLP-1s, it was known that even modest weight-loss improved obesity-related conditions and that this had had no negative impact on the MedTech market, as illustrated below
Plaintiffs pursuing such claims now face two choices: they can either file a new MDL focusing solely on blood clot injuries or litigate the cases separately in state or federal courts nationwide
These drugs mimic the effects of GLP-1, a naturally occurring hormone that is released after eating
